Literature DB >> 26405535

Advances in the clinical research of the minimally invasive treatment for the posterior edge of vertebral-body defects by spinal metastases.

Xuefeng Liu1, Zuozhang Yang1, Lin Xie1, Zongqin Yuan1, Mingyan Ren1, Lei Han1.   

Abstract

Spinal metastasis is one of the commonly observed complications in the advanced stages of cancer patients, and is a serious threat to human life and health. Malignant tumor invasion usually leads to defects in the posterior margins of the vertebral body, which caused significant cancer pains to patients and increased the risk of surgery. Currently, minimally invasive treatments of vertebral defects caused by spinal metastases include percutaneous vertebroplasty (PVP) combined with radiofrequency ablation and PVP combined with 125I seed implantation. These minimally invasive techniques have particular superiority to control pain in patients with spinal metastases, improve nerve function, reduce the incidence of fractures and surgical risk, and improve the quality of life. The present study reviewed the progress in clinical research on vertebral defects caused by spinal metastases, and the mechanisms and minimally invasive treatment.

Entities:  

Keywords:  clinical research; minimally invasive treatment; posterior vertebral-body defects; spinal metastases

Year:  2015        PMID: 26405535      PMCID: PMC4535057          DOI: 10.3892/br.2015.483

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  43 in total

1.  Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment.

Authors:  Yuya Koike; Kenji Takizawa; Yukihisa Ogawa; Ayako Muto; Misako Yoshimatsu; Kunihiro Yagihashi; Yasuo Nakajima
Journal:  Cardiovasc Intervent Radiol       Date:  2010-11-13       Impact factor: 2.740

2.  Percutaneous CT-guided biopsy of the spine: results of 430 biopsies.

Authors:  Eugenio Rimondi; Eric L Staals; Costantino Errani; Giuseppe Bianchi; Roberto Casadei; Marco Alberghini; Maria Cristina Malaguti; Giuseppe Rossi; Stefano Durante; Mario Mercuri
Journal:  Eur Spine J       Date:  2008-05-08       Impact factor: 3.134

3.  Total en bloc spondylectomy and a greater omentum pedicle flap for a large bone and soft tissue defect: solitary lumbar metastasis from renal cell carcinoma.

Authors:  Norio Kawahara; Katsuro Tomita; Hideki Murakami; Satoru Demura; Kazuhiko Satomi; Yutaka Atomi
Journal:  J Orthop Sci       Date:  2009-12-08       Impact factor: 1.601

4.  A patient with lung cancer metastatic to the fifth thoracic vertebra and spinal cord compression treated with percutaneous vertebroplasty and I-125 seed implantation.

Authors:  Yang Zuozhang; Xie Lin; Sun Hongpu; Huang Yunnchao; Ma Xiang; Yuan Tao; Zhang Jinlei; Zhao Ruilian
Journal:  Diagn Interv Radiol       Date:  2011-09-27       Impact factor: 2.630

5.  Vertebroplasty: benefits are more than risks in selected and evidence-based informed patients. A retrospective study of 59 cases.

Authors:  Giovanni Barbanti Brodano; Luca Amendola; Konstantinos Martikos; Camilla Bettuzzi; Luca Boriani; Alessandro Gasbarrini; Stefano Bandiera; Silvia Terzi; Tiziana Greggi; Stefano Boriani
Journal:  Eur Spine J       Date:  2011-02-12       Impact factor: 3.134

6.  Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases.

Authors:  Frédéric Clarençon; Betty Jean; Hang-Phuong Pham; Evelyne Cormier; Gilbert Bensimon; Michèle Rose; Philippe Maksud; Jacques Chiras
Journal:  Skeletal Radiol       Date:  2011-11-13       Impact factor: 2.199

7.  Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.

Authors:  Michael P Mac Manus; Rodney J Hicks; Jane P Matthews; Andrew Wirth; Danny Rischin; David L Ball
Journal:  Lung Cancer       Date:  2005-02-17       Impact factor: 5.705

8.  Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid.

Authors:  Allan Lipton; Richard Cook; Fred Saad; Pierre Major; Patrick Garnero; Evangelos Terpos; Janet E Brown; Robert E Coleman
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

9.  Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.

Authors:  I Breitkreutz; M S Raab; S Vallet; T Hideshima; N Raje; C Mitsiades; D Chauhan; Y Okawa; N C Munshi; P G Richardson; K C Anderson
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

10.  Percutaneous radiofrequency ablation of osteoid osteomas with use of real-time needle guidance for accurate needle placement: a pilot study.

Authors:  Wendy M H Busser; Yvonne L Hoogeveen; Rene P H Veth; H W Bart Schreuder; Angelique Balguid; W KlaasJan Renema; Leo J Schultzekool
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-29       Impact factor: 2.740

View more
  1 in total

1.  Thermal effect of percutaneous radiofrequency ablation with a clustered electrode for vertebral tumors: In vitro and vivo experiments and clinical application.

Authors:  Wei Zhao; Zhao-Hong Peng; Jin-Zhou Chen; Ji-Hong Hu; Jian-Qiang Huang; Yong-Neng Jiang; Gang Luo; Gen-Fa Yi; Hui Wang; Shen Jin; Bu-Lang Gao
Journal:  J Bone Oncol       Date:  2018-07-20       Impact factor: 4.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.